JAGLX Holdings Information

JAGLX is a mutual fund with a total of 98 individual holdings. The top holdings are Eli Lilly and Company stock at 9.59%, Johnson & Johnson at 7.76%, AbbVie at 4.92%, UnitedHealth Group at 4.26%, and AstraZeneca at 3.66%.

Total Holdings

Top 10 Percentage

43.67%

Asset Class

Equity

Fund Category

Health

Assets

6.20B

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.59%	479,580
2	JNJ	Johnson & Johnson	7.76%	1,695,689
3	ABBV	AbbVie Inc.	4.92%	1,088,771
4	UNH	UnitedHealth Group Incorporated	4.26%	672,265
5	LON: AZN	AstraZeneca PLC	3.66%	1,315,670
6	TMO	Thermo Fisher Scientific Inc.	3.34%	285,966
7	NVSN.MX	Novartis AG ADR	2.71%	1,100,835
8	SWX: ROP	Roche Holding AG	2.65%	369,830
9	ARGX	argenx SE	2.44%	147,181
10	MRK	Merck & Co., Inc.	2.34%	932,725
11	ABT	Abbott Laboratories	2.23%	1,307,338
12	DHR	Danaher Corporation	2.10%	549,686
13	RVMD	Revolution Medicines, Inc.	2.03%	571,877
14	ISRG	Intuitive Surgical, Inc.	2.02%	287,578
15	PRAX	Praxis Precision Medicines, Inc.	1.93%	383,827
16	BBIO	BridgeBio Pharma, Inc.	1.91%	1,678,969
17	GILD	Gilead Sciences, Inc.	1.87%	724,620
18	CVS	CVS Health Corporation	1.85%	1,252,195
19	VRTX	Vertex Pharmaceuticals Incorporated	1.80%	199,317
20	AMGN	Amgen Inc.	1.61%	221,570
21	EPA: SAN	Sanofi	1.53%	1,077,152
22	TVTX	Travere Therapeutics, Inc.	1.40%	1,376,986
23	ASND	Ascendis Pharma A/S	1.39%	352,435
24	SYK	Stryker Corporation	1.38%	289,997
25	MDGL	Madrigal Pharmaceuticals, Inc.	1.34%	153,831

Showing 25 of 98 holdings

Subscribe to see the full list

Activate Now

As of Sep 30, 2026